CSI Market
Sign In | Register

Universe Pharmaceuticals Inc (UPC) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access UPC quarterly Cash Flow →
Examining cash flow movements between Universe Pharmaceuticals Inc and Sep 30 2021 reveals how Sep 30 2025 allocates cash as operating conditions evolve.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
12 Months 		(Sep 30 2024) (Sep 30 2023) (Sep 30 2022) (Sep 30 2021)
Operating Activities
Income-3,672.06
Depreciation & amortization474.18
Amortization of Other Assets43.25
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Other Asset Impairment Charges481.11
Provision For Loan Losses Expensed-113.45
Increase (Decrease) in Inventories474.63
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total-2.95
Share-based Compensation284.00
Income (Loss) from Equity Method Investments65.06
Financial Instruments and Foreign Currency Transaction0.00
Change In Fair Value Of Shortterm Investments-
Increase Decrease In Contract With Customer Liability40.18
Income taxes-324.53
Losses/ -gains on Investments net0.00
Accounts Receivable168.96
Increase (Decrease) in Accounts Payable-3,132.71
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-85.44
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets-789.96
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-5,052.32
Investing Activities
Capital Expenditures80.42
Sale of Capital Items5.38
Payments for (Proceeds from) Short-term Investments, Total0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Redemption Of Shortterm Investments-
Proceeds From Payment For Construction In Progress-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-341.81
Financing Activities
Short-term debt Net7,057.19
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments3,213.43
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock15,000.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds Fromprepayments For Related Parties Borrowings-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities9,726.13
Effect of exchange rate on cash flow-237.67
Discontinued operations0.00
Free Cash Flow-4,966.52
Total Cash Flow4,094.33
4 historic quarters locked

Sign in to unlock the full Universe Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Universe Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-009000

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License